查看购物车
  • Traditional Chinese
  • English
细胞和基因治疗合约开发和製造组织市场规模及预测 2021 - 2031、全球和区域份额、趋势和成长机会分析报告涵盖范围：按服务类型、产品类型、最终用户和地理划分
市场调查报告书
商品编码
1761163

细胞和基因治疗合约开发和製造组织市场规模及预测 2021 - 2031、全球和区域份额、趋势和成长机会分析报告涵盖范围：按服务类型、产品类型、最终用户和地理划分

Cell and Gene Therapy Contract Development and Manufacturing Organization Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type, Product Type, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 249 Pages | 订单完成后即时交付

价格

根据我们最新的研究报告《细胞和基因治疗合约开发与製造组织市场预测（2031年）—全球分析—按服务类型、产品类型、最终用户和地理划分》，预计该市场规模将从2024年的62.2亿美元增长到2031年的318.6亿美元；预计2025-2031年期间的复合年增长率为2025-2031年。创新疗法临床试验的增加以及监管审批和商业化的激增，正在推动细胞和基因治疗合约开发与製造组织市场规模的不断增长。然而，製造环节的高复杂性阻碍了细胞和基因治疗合约开发与製造组织市场的成长。此外，人工智慧和数位转型的不断融合预计将在未来几年带来新的细胞和基因治疗合约开发与製造组织市场趋势。

就收入而言，北美在 2024 年占据市场主导地位。预计在预测期内，它将占据全球市场主导地位。美国是世界上最大的细胞和基因治疗合约开发和製造组织市场。美国正在经历生物技术的不断进步、遗传疾病的日益普及以及对专业製造服务的需求激增。根据美国政府问责局 2021 年 10 月发布的估计，该国约有 2,500 万至 3,000 万人患有罕见疾病。根据美国食品药物管理局 (FDA) 的数据，超过 7,000 种罕见疾病影响着全国超过 3,000 万人。对这些疾病的了解日益加深导致基因治疗发展的激增。 CDMO 透过为针对罕见遗传疾病的基因疗法的开发和製造提供专业服务，在这一领域发挥着至关重要的作用。

2023年，美国FDA批准了许多细胞和基因疗法，包括针对罕见疾病的基因编辑疗法。用于治疗镰状细胞疾病的exagamglogene autotemcel（Casgevy）和lovotibeglogene autotemcel，以及用于治疗重症血友病A的valoctocogene roxaparvovec等疗法均已获得FDA批准，凸显了基因疗法在应对罕见疾病挑战方面的潜力。再生医学先进疗法（RMAT）认证等加速的监管途径，促使生物技术公司与CDMO合作，以扩大生产规模。

製造业基础设施的投资促进了市场的成长。由15家学术机构、超过25家公司和政府机构合作成立的国家细胞製造联盟 (National Cell Manufacturing Consortium) 旨在实现细胞疗法的经济高效、大规模生产。此外，CDMO、学术机构和生物製药公司之间的策略合作也促进了市场的成长。

细胞和基因治疗合约开发和製造组织市场分析

获得专业设施和技术，为未来提供市场机会

细胞和基因疗法的需求正推动生物製药公司寻求能够提供尖端设施和技术的CDMO，这些设施和技术是扩大生产规模、确保品质、合规性和获得监管批准的必要条件。这些专业能力对于复杂和个人化疗法的生产至关重要，而这些疗法需要先进的基础设施来维持高生产标准。细胞和基因疗法，包括基因编辑、病毒载体生产和个人化医疗，需要配备最新技术的专业设施。基因疗法中使用的病毒载体的生产需要符合GMP标准的设施，以确保最终产品的安全性、一致性和品质。这些设施应能够在受控和监控的环境中处理复杂的生物材料，例如活细胞和基因改造生物。自动化细胞培养系统、连续生产和数位化品质监控系统的日益普及，提高了基因疗法生产的成长和效率。例如，2025年3月，Bharat Biotech公司在印度南部投资7,500万美元建立了其首个细胞和基因治疗设施，预计在未来3年内推出针对肿瘤和罕见疾病的新疗法。

对专业设施的需求为CDMO创造了巨大的机会。对于生物製药公司来说，与拥有所需技术和设施的CDMO合作既经济高效，又能节省成本。例如，2023年，百时美施贵宝与CDMO合作生产其CAR-T细胞疗法Breyanzi。此疗法涉及采集、改造和扩增患者的T细胞，此过程需要专业的技术和设施才能确保达到预期的治疗效果。透过利用CDMO在专业设施方面的专业知识，百时美施贵宝得以在确保合规性和品质的同时扩大生产规模。因此，对先进製​​造能力和先进技术的不断增长的需求预计将为细胞和基因治疗合约研发组织市场创造未来的成长机会。

细胞和基因治疗合约开发和製造组织市场报告細項分析

有助于得出细胞和基因治疗合约开发和製造组织市场分析的关键部分是服务类型、产品类型和最终用户。

根据服务类型，细胞和基因治疗合约开发与製造组织市场细分为药物开发与製造、检测与监管服务以及其他服务。药物开发与製造领域在2024年占据了最大的市场。

就产品类型而言，细胞和基因治疗合约开发与製造组织市场分为基因治疗和细胞治疗。 2024年，细胞治疗领域占据市场主导地位。

根据最终用户，细胞和基因治疗合约开发与製造组织市场可分为製药公司、生物製药公司和其他公司。 2024年，生物製药公司占据了市场主导地位。

细胞和基因治疗合约开发和製造组织市场：竞争格局和关键发展

药明生物技术有限公司、Charles River Laboratories International Inc、Catalent Inc、Lonza Group AG、赛默飞世尔科技公司、AGC Biologics AS、Takara Bio Inc、富士胶片控股公司、Pluri Inc、SK pharmteco Inc、Aenova Holding GmbH 和 Minaris Advanced Therapies 是细胞和基因治疗合约开发和製造组织市场的主要开发公司。

加拿大统计局、世界人口展望、Globocan、巴西卫生监管机构 (ANVISA)、再生医学联盟 (ARM) 和食品药物管理局 (FDA) 是编写细胞和基因治疗合约开发和製造组织市场报告时参考的主要和次要来源。

目录

第一章：简介

第二章：执行摘要

  • 分析师市场展望

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第四章：细胞和基因治疗合约开发和製造组织市场格局

  • 概述
  • 全球质粒製造市场

第五章：细胞和基因治疗合约开发和製造组织市场-关键市场动态

  • 细胞和基因治疗合约开发和製造组织市场-关键市场动态
  • 市场驱动因素
    • 增加创新疗法的临床试验
    • 监管审批和商业化激增
  • 市场限制
    • 製造复杂性高
  • 市场机会
    • 使用专业设施和技术
  • 未来趋势
    • 人工智慧与数位转型日益融合
  • 驱动因素和限制因素的影响：

第六章：细胞和基因治疗合约开发和製造组织市场-全球市场分析

  • 细胞和基因治疗合约开发和製造组织市场收入（2021-2031）
  • 细胞和基因治疗合约开发和製造组织市场预测分析

第七章：细胞和基因治疗合约开发和製造组织市场分析-按服务类型

  • 药物开发与製造
  • 测试和监管服务
  • 其他的

第八章：细胞和基因治疗合约开发和製造组织市场分析-按产品类型

  • 基因治疗
  • 细胞疗法

第九章：细胞和基因治疗合约开发和製造组织市场分析—按最终用户

  • 製药公司
  • 生物製药公司
  • 其他的

第 10 章：细胞和基因治疗合约开发和製造组织市场-地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章：竞争格局

  • 2024年全球公司市占率分析

第 12 章：产业格局

  • 概述
  • 扩张
  • 新产品开发
  • 合併与收购
  • 合作伙伴关係
  • 其他商业策略

第十三章：公司简介

  • WuXi Biologics Inc
  • Charles River Laboratories International Inc
  • Catalent Inc
  • Lonza Group AG
  • Thermo Fisher Scientific Inc.
  • AGC Biologics AS
  • Takara Bio Inc
  • FUJIFILM Holdings Corp
  • Pluri Inc
  • SK pharmteco Inc
  • Aenova Holding GmbH
  • Minaris Advanced Therapies

第 14 章：附录

Product Code: TIPRE00040769

According to our new research study on "Cell and Gene Therapy Contract Development and Manufacturing Organization Market Forecast to 2031 -Global Analysis - by Service Type, Product Type, End User, and Geography," the market is anticipated to grow from US$ 6.22 billion in 2024 and is projected to reach US$ 31.86 billion by 2031; it is expected to register a CAGR of 26.4% during 2025-2031. Increasing clinical trials for innovative therapies and surging regulatory approvals and commercialization are contributing to the growing cell and gene therapy contract development and manufacturing organization market size. However, the high manufacturing complexities hampers the cell and gene therapy contract development and manufacturing organization market growth. Further, rising integration of AI and digital transformation is expected to bring in new cell and gene therapy contract development and manufacturing organization market trends in the coming years.

In terms of revenue, North America dominated the market in 2024. It is estimated to dominate the global market during the forecast period. The US is the largest market for cell and gene therapy contract development and manufacturing organization in the world. The US is observing growing advancements in biotechnology, an increasing prevalence of genetic diseases, and surging demand for specialized manufacturing services. As per the estimates of the US Government Accountability Office published in October 2021, ~25 to 30 million people suffer from rare diseases in the country. As per the Food and Drug Administration (FDA), more than 7,000 rare diseases affect over 30 million people in the country. The growing understanding of these diseases has led to a surge in gene therapy development. CDMOs play a crucial role in this space by providing specialized services for the development and manufacturing of gene therapies targeting rare genetic disorders.

In 2023, the US FDA approved numerous cell and gene therapies, including gene-editing treatments targeting rare diseases. Therapies such as exagamglogene autotemcel (Casgevy) and lovotibeglogene autotemcel for sickle cell disease, as well as valoctocogene roxaparvovec for severe hemophilia A, have received FDA approval, highlighting the potential of gene therapies in addressing rare disease challenges. The accelerated regulatory pathways, such as the Regenerative Medicine Advanced Therapy (RMAT) designation, have spurred biotechnology companies to partner with CDMOs for scaling production.

Investments in manufacturing infrastructure have bolstered the market growth. The National Cell Manufacturing Consortium, established through collaboration between 15 academic institutes, over 25 companies, and government agencies, aims to enable cost-effective, large-scale manufacturing of cell therapies. In addition, strategic collaborations between CDMOs, academic institutions, and biopharma companies also contribute to market growth.

Cell and Gene Therapy Contract Development and Manufacturing Organization Market Analysis

Access to Specialized Facilities and Technologies to Provide Market Opportunities in Future

The demand for cell and gene therapies is driving biopharmaceutical companies toward CDMOs that can provide cutting-edge facilities and technologies, which are required to scale up production while ensuring quality, compliance, and regulatory approval. These specialized capabilities are essential for the production of complex and personalized therapies, which require advanced infrastructure to maintain high manufacturing standards. Cell and gene therapies, including gene editing, viral vector production, and personalized medicine, require specialized facilities equipped with the latest technologies. The production of viral vectors used in gene therapies requires GMP standard facilities to ensure the safety, consistency, and quality of the final product. These facilities should be equipped to handle complex biological materials, such as live cells and genetically modified organisms, in controlled and monitored environments. The increasing adoption of automated cell culture systems, continuous manufacturing, and digital quality monitoring systems enhances the growth and efficiency of gene therapy production. For instance, in March 2025, Bharat Biotech invested US$ 75 million in its first cell and gene therapy facility in the southern India which is expected to launch new therapies in next 3 years for oncology and rare disease.

The need for specialized facilities creates a substantial opportunity for CDMOs. It is cost-effective and efficient for biopharma companies to collaborate with CDMOs that have the required technology and facilities. For instance, in 2023, Bristol-Myers Squibb collaborated with a CDMO for the production of its CAR-T cell therapy, Breyanzi. This therapy involves harvesting, modifying, and expanding a patient's T-cells, a process requiring specialized technology and facilities to ensure the desired therapeutic effect. By leveraging CDMO expertise in specialized facilities, Bristol-Myers Squibb was able to scale production while ensuring regulatory compliance and quality. Thus, the soaring need for advanced manufacturing capabilities with advanced technology is expected to create future growth opportunities for the cell and gene therapy contract research and development organization market.

Cell and Gene Therapy Contract Development and Manufacturing Organization Market Report Segmentation Analysis

Key segments that contributed to the derivation of the cell and gene therapy contract development and manufacturing organization market analysis are service type, product type, and end user.

Based on service type, the cell and gene therapy contract development and manufacturing organization market is segmented into drug development and manufacturing, testing and regulatory services, and others. The drug development and manufacturing segment held the largest share of the market in 2024.

In terms of product type, the cell and gene therapy contract development and manufacturing organization market is bifurcated into gene therapy and cell therapy. The cell therapy segment dominated the market in 2024.

By end user, the cell and gene therapy contract development and manufacturing organization market is categorized into pharmaceutical companies, biopharmaceutical companies, and others. The biopharmaceutical companies segment dominated the market in 2024.

Cell and Gene Therapy Contract Development and Manufacturing Organization Market: Competitive Landscape and Key Developments

WuXi Biologics Inc, Charles River Laboratories International Inc, Catalent Inc, Lonza Group AG, Thermo Fisher Scientific Inc., AGC Biologics AS, Takara Bio Inc, FUJIFILM Holdings Corp, Pluri Inc, SK pharmteco Inc, Aenova Holding GmbH, and Minaris Advanced Therapies are among the key companies operating in the cell and gene therapy contract development and manufacturing organization market.

Statistics Canada, World Population Prospectus, Globocan, Brazilian Health Regulatory Agency (ANVISA), Alliance for Regenerative Medicine (ARM), and the Food and Drug Administration (FDA) are among the primary and secondary sources referred to while preparing the cell and gene therapy contract development and manufacturing organization market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Landscape

  • 4.1 Overview
  • 4.2 Global Plasmid Manufacturing Market

5. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Key Market Dynamics

  • 5.1 Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Clinical Trials for Innovative Therapies
    • 5.2.2 Surging Regulatory Approvals and Commercialization
  • 5.3 Market Restraints
    • 5.3.1 High Manufacturing Complexities
  • 5.4 Market Opportunities
    • 5.4.1 Access to Specialized Facilities and Technologies
  • 5.5 Future Trends
    • 5.5.1 Rising Integration of AI and Digital Transformation
  • 5.6 Impact of Drivers and Restraints:

6. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Global Market Analysis

  • 6.1 Cell And Gene Therapy Contract Development and Manufacturing Organization Market Revenue (US$ Million), 2021-2031
  • 6.2 Cell And Gene Therapy Contract Development and Manufacturing Organization Market Forecast Analysis

7. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Analysis - by Service Type

  • 7.1 Drug Development and Manufacturing
    • 7.1.1 Overview
    • 7.1.2 Drug Development and Manufacturing: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Testing and Regulatory Services
    • 7.2.1 Overview
    • 7.2.2 Testing and Regulatory Services: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Others
    • 7.3.1 Overview
    • 7.3.2 Others: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)

8. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Analysis - by Product Type

  • 8.1 Gene Therapy
    • 8.1.1 Overview
    • 8.1.2 Gene Therapy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Cell Therapy
    • 8.2.1 Overview
    • 8.2.2 Cell Therapy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)

9. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Analysis - by End User

  • 9.1 Pharmaceutical Companies
    • 9.1.1 Overview
    • 9.1.2 Pharmaceutical Companies: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Biopharmaceutical Companies
    • 9.2.1 Overview
    • 9.2.2 Biopharmaceutical Companies: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)

10. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Geographical Analysis

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 North America Cell And Gene Therapy Contract Development and Manufacturing Organization Market Overview
    • 10.2.2 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
      • 10.2.2.1 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Service Type
      • 10.2.2.2 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Product Type
      • 10.2.2.3 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by End User
    • 10.2.3 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.2.3.1 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.2.3.2 United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.2.3.2.1 United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.2.3.2.2 United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.2.3.2.3 United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.2.3.3 Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.2.3.3.1 Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.2.3.3.2 Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.2.3.3.3 Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.2.3.4 Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.2.3.4.1 Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.2.3.4.2 Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.2.3.4.3 Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
  • 10.3 Europe
    • 10.3.1 Europe Cell And Gene Therapy Contract Development and Manufacturing Organization Market Overview
    • 10.3.2 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
      • 10.3.2.1 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Service Type
      • 10.3.2.2 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Product Type
      • 10.3.2.3 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by End User
    • 10.3.3 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.3.3.1 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.3.3.2 Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.3.3.2.1 Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.3.3.2.2 Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.3.3.2.3 Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.3.3.3 United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.3.3.3.1 United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.3.3.3.2 United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.3.3.3.3 United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.3.3.4 France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.3.3.4.1 France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.3.3.4.2 France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.3.3.4.3 France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.3.3.5 Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.3.3.5.1 Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.3.3.5.2 Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.3.3.5.3 Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.3.3.6 Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.3.3.6.1 Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.3.3.6.2 Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.3.3.6.3 Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.3.3.7 Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.3.3.7.1 Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.3.3.7.2 Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.3.3.7.3 Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific Cell And Gene Therapy Contract Development and Manufacturing Organization Market Overview
    • 10.4.2 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
      • 10.4.2.1 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Service Type
      • 10.4.2.2 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Product Type
      • 10.4.2.3 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by End User
    • 10.4.3 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.4.3.1 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.4.3.2 China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.4.3.2.1 China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.4.3.2.2 China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.4.3.2.3 China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.4.3.3 Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.4.3.3.1 Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.4.3.3.2 Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.4.3.3.3 Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.4.3.4 India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.4.3.4.1 India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.4.3.4.2 India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.4.3.4.3 India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.4.3.5 Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.4.3.5.1 Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.4.3.5.2 Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.4.3.5.3 Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.4.3.6 South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.4.3.6.1 South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.4.3.6.2 South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.4.3.6.3 South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.4.3.7 Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.4.3.7.1 Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.4.3.7.2 Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.4.3.7.3 Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
  • 10.5 Middle East and Africa
    • 10.5.1 Middle East and Africa Cell And Gene Therapy Contract Development and Manufacturing Organization Market Overview
    • 10.5.2 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
      • 10.5.2.1 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Service Type
      • 10.5.2.2 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Product Type
      • 10.5.2.3 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by End User
    • 10.5.3 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.5.3.1 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.5.3.2 Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.5.3.2.1 Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.5.3.2.2 Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.5.3.2.3 Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.5.3.3 South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.5.3.3.1 South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.5.3.3.2 South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.5.3.3.3 South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.5.3.4 United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.5.3.4.1 United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.5.3.4.2 United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.5.3.4.3 United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.5.3.5 Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.5.3.5.1 Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.5.3.5.2 Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.5.3.5.3 Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
  • 10.6 South and Central America
    • 10.6.1 South and Central America Cell And Gene Therapy Contract Development and Manufacturing Organization Market Overview
    • 10.6.2 South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
      • 10.6.2.1 South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Service Type
      • 10.6.2.2 South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Product Type
      • 10.6.2.3 South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by End User
      • 10.6.2.4 South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
      • 10.6.2.5 Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.6.2.5.1 Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.6.2.5.2 Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.6.2.5.3 Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.6.2.6 Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.6.2.6.1 Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.6.2.6.2 Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.6.2.6.3 Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
      • 10.6.2.7 Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
        • 10.6.2.7.1 Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
        • 10.6.2.7.2 Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
        • 10.6.2.7.3 Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User

11. Competitive Landscape

  • 11.1 Global Company Market Share Analysis, 2024

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Expansion
  • 12.3 New Product Development
  • 12.4 Merger and Acquisition
  • 12.5 Partnerships
  • 12.6 Other Business Strategies

13. Company Profiles

  • 13.1 WuXi Biologics Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Charles River Laboratories International Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Catalent Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Lonza Group AG
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Thermo Fisher Scientific Inc.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 AGC Biologics AS
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Takara Bio Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 FUJIFILM Holdings Corp
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Pluri Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 SK pharmteco Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Aenova Holding GmbH
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Minaris Advanced Therapies
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments

14. Appendix

  • 14.1 Glossary of Terms
  • 14.2 About The Insight Partners

List Of Tables

  • Table 1. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Segmentation
  • Table 2. Global Plasmid Manufacturing Market, US$ Million, 2021-2031
  • Table 3. Global Plasmid Manufacturing Market, By Type, 2021-2031 (US$ Million)
  • Table 4. Global Plasmid Manufacturing Market, By Application, 2021-2031 (US$ Million)
  • Table 5. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million)
  • Table 6. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million)
  • Table 7. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 8. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 9. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 10. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 11. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 12. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 13. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Service Type
  • Table 14. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 15. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Product Type
  • Table 16. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 17. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by End User
  • Table 18. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 19. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Country
  • Table 20. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Country
  • Table 21. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 22. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 23. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 24. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 25. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 26. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 27. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 28. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 29. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 30. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 31. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 32. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 33. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 34. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 35. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 36. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 37. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 38. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 39. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Service Type
  • Table 40. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 41. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Product Type
  • Table 42. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 43. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by End User
  • Table 44. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 45. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Country
  • Table 46. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Country
  • Table 47. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 48. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 49. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 50. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 51. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 52. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 53. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 54. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 55. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 56. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 57. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 58. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 59. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 60. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 61. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 62. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 63. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 64. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 65. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 66. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 67. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 68. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 69. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 70. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 71. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 72. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 73. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 74. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 75. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 76. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 77. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 78. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 79. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 80. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 81. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 82. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 83. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Service Type
  • Table 84. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 85. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Product Type
  • Table 86. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 87. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by End User
  • Table 88. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 89. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Country
  • Table 90. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Country
  • Table 91. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 92. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 93. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 94. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 95. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 96. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 97. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 98. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 99. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 100. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 101. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 102. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 103. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 104. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 105. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 106. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 107. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 108. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 109. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 110. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 111. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 112. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 113. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 114. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 115. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 116. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 117. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 118. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 119. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 120. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 121. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 122. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 123. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 124. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 125. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 126. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 127. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Service Type
  • Table 128. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 129. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Product Type
  • Table 130. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 131. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by End User
  • Table 132. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 133. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Country
  • Table 134. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Country
  • Table 135. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 136. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 137. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 138. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 139. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 140. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 141. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 142. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 143. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 144. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 145. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 146. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 147. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 148. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 149. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 150. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 151. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 152. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 153. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 154. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 155. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 156. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 157. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 158. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 159. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Service Type
  • Table 160. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 161. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Product Type
  • Table 162. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 163. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by End User
  • Table 164. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 165. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Country
  • Table 166. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Country
  • Table 167. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 168. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 169. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 170. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 171. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 172. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 173. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 174. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 175. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 176. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 177. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 178. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
  • Table 179. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
  • Table 180. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
  • Table 181. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
  • Table 182. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
  • Table 183. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
  • Table 184. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User

List Of Figures

  • Figure 1. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Revenue (US$ Million), 2021-2031
  • Figure 5. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Share (%) - by Service Type (2024 and 2031)
  • Figure 6. Drug Development and Manufacturing: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Testing and Regulatory Services: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Others: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Share (%) - by Product Type (2024 and 2031)
  • Figure 10. Gene Therapy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Cell Therapy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Share (%) - by End User (2024 and 2031)
  • Figure 13. Pharmaceutical Companies: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Biopharmaceutical Companies: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Others: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown by Region, 2024 and 2031 (%)
  • Figure 17. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 18. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 19. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 20. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 21. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 22. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 23. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 24. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 25. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 26. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 27. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 28. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 29. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 30. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 31. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 32. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 33. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 34. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 35. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 36. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 37. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 38. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 39. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 40. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 41. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 42. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 43. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 44. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 45. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 46. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 47. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
  • Figure 48. Global Company Market Share Analysis, 2024